Spruce Biosciences, Inc.
NASDAQ:SPRB · NASDAQ Capital Market
+$2.47 today
Vol 0.14M · Avg 0.06M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+897.33%
Period High
$182.60
Period Low
$5.25
Latest
$52.36
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Equillium, Inc.
NASDAQ:EQ
$107.81M
vTv Therapeutics Inc.
NASDAQ:VTVT
$90.45M
OS Therapies Incorporated
AMEX:OSTX
$81.73M
Cue Biopharma, Inc.
NASDAQ:CUE
$71.06M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$69.75M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$63.77M
Coeptis Therapeutics, Inc.
NASDAQ:COEP
$55.98M
Werewolf Therapeutics, Inc.
HOWL
$17.12M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest SPRB filing?
The latest filing shown is 4 dated May 26, 2026.
How many recent filings does SPRB have?
Intrinsic Alpha currently shows 20 recent filings for SPRB.
Explore More
Continue the stock analysis
Jump to another research area for this company.